MSN: Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches

DHSC has published a Tier 2 Medicine Supply Notification (MSN) for: Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches: out of stock until late-February 2026

Up-to-date information about this and other medicine supply issues can be found in the DHSC and NHSE online Medicines Supply Tool

Supply Shortages

Latest news

DDA podcast looks at private weight loss clinics

Oral orforglipron GLP1 (marketed in the USA by Lilly as Foundayo) was authorised for use in weight management and type 2 diabetes in August 2026, in a UK first. In this new DDA podcast, the 12th in our series, DDA Communications Officer Ailsa Colquh

DDA raises rural GP issues in Westminster event

DDA Board Member Dr Ian Hume raised the rural challenges facing dispensing GPs in a Rebuild General Practice campaign roundtable with Liberal Democrat MPs.The discussion focused on the challenges facing GP practices across the country, from rising de

MSN: lansoprazole 15mg and 30mg orodispersible tablets

DHSC has published a Tier 2 Medicine Supply Notification (MSN) for lansoprazole 15mg and 30mg orodispersible tablets: limited supply until early January 2027. Up-to-date information abour medicine supply issues can be found in the DHSC and NHSE